Pure Global

Breathing Relaxation Exercise Heart Failure - Trial NCT05905627

Access comprehensive clinical trial information for NCT05905627 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Yalova and is currently Completed. The study focuses on Congestive Heart Failure. Target enrollment is 65 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05905627
Completed
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT05905627
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Breathing Relaxation Exercise Heart Failure
The Effect of Breathing and Relaxation Exercise on Dyspnea, Fatigue and Self-Care Level

Study Focus

Congestive Heart Failure

exercise

Observational

behavioral

Sponsor & Location

University of Yalova

Yalova, Turkey

Timeline & Enrollment

N/A

Jun 06, 2023

Jun 21, 2023

65 participants

Primary Outcome

The effect of ephesus exercise on the mean fatigue score

Summary

The aim of the study is to determine the effect of breathing and relaxation exercises on
 dyspnea, fatigue and self-care level in heart failure patients.

ICD-10 Classifications

Congestive heart failure
Heart failure
Hypertensive heart disease with (congestive) heart failure
Hypertensive heart and renal disease with (congestive) heart failure
Heart failure, unspecified

Data Source

ClinicalTrials.gov

NCT05905627

Non-Device Trial